Matches in SemOpenAlex for { <https://semopenalex.org/work/W2979595568> ?p ?o ?g. }
Showing items 1 to 72 of
72
with 100 items per page.
- W2979595568 endingPage "S21" @default.
- W2979595568 startingPage "S21" @default.
- W2979595568 abstract "Several approaches have been proposed to address the challenge of catheter ablation of persistent AF. However, the optimal ablation strategy is unknown. In this study, we sought to evaluate procedural outcomes after pulmonary vein isolation (PVI) plus low voltage area (LVA) ablation in patients with persistent AF. Methods: Consecutive patients accepted for EP study and AF catheter ablation for persistent AF were eligible for the study. High density bipolar voltage mapping data was acquired in sinus rhythm using multipolar catheters to detect LVA (defined as bipolar voltage < 0.5mV). A semi-automated software was used to ensure catheter contact and homogeneous data collection (Confidense, Biosense Webster, Inc). Patients underwent standard of care PVI followed by LVA ablation according to a standardized protocol. Results: A total of 172 patients were studied; 86 subjects undergoing PVI + LVA ablation were compared to 86 consecutive historical controls (PVI ± CFE/lines). Average age was 61 ± 9 years, 79% were male. The mean LA volume was 89 ± 25ml, LVEF 53 ± 7. Baseline characteristics were comparable). Average follow-up duration was 19 ± 7 vs 30 ±12 months in controls (P < 0.001). Freedom from AF (single procedure success) at 12 months was 72% after PVI + LVA ablation vs 53% in controls (P=0.01). Survival analysis is shown in Figure 1. Median procedure duration (300min [250,360] vs 311 (273, 376)]; P=0.05) and RF delivery (52min [43,64] vs 59 [46,76]; P=0.02) were longer in the PVI + LVA ablation group. Multivariable analysis showed that ablation strategy (PVI+LVA ablation) was an independent predictor of freedom from AT/AF (HR 0.44; 95%CI 0.25-0.71; P=0.001). There were no adverse safety outcomes associated with LVA ablation. This observational study shows that an individualized strategy of PVI + LVA ablation is associated with improved outcomes in patients with persistent AF. Adequately powered randomized clinical trials are needed to determine the role of PVI + LVA ablation for persistent AF." @default.
- W2979595568 created "2019-10-18" @default.
- W2979595568 creator A5002947500 @default.
- W2979595568 creator A5014673298 @default.
- W2979595568 creator A5030732786 @default.
- W2979595568 creator A5038197407 @default.
- W2979595568 creator A5040433180 @default.
- W2979595568 creator A5055875512 @default.
- W2979595568 creator A5062337728 @default.
- W2979595568 creator A5082161859 @default.
- W2979595568 date "2019-10-01" @default.
- W2979595568 modified "2023-09-26" @default.
- W2979595568 title "ATRIAL SCAR ABLATION IN ADDITION TO PULMONARY VEIN ISOLATION FOR PERSISTENT ATRIAL FIBRILLATION: A PILOT STUDY" @default.
- W2979595568 doi "https://doi.org/10.1016/j.cjca.2019.07.084" @default.
- W2979595568 hasPublicationYear "2019" @default.
- W2979595568 type Work @default.
- W2979595568 sameAs 2979595568 @default.
- W2979595568 citedByCount "0" @default.
- W2979595568 crossrefType "journal-article" @default.
- W2979595568 hasAuthorship W2979595568A5002947500 @default.
- W2979595568 hasAuthorship W2979595568A5014673298 @default.
- W2979595568 hasAuthorship W2979595568A5030732786 @default.
- W2979595568 hasAuthorship W2979595568A5038197407 @default.
- W2979595568 hasAuthorship W2979595568A5040433180 @default.
- W2979595568 hasAuthorship W2979595568A5055875512 @default.
- W2979595568 hasAuthorship W2979595568A5062337728 @default.
- W2979595568 hasAuthorship W2979595568A5082161859 @default.
- W2979595568 hasConcept C126322002 @default.
- W2979595568 hasConcept C141071460 @default.
- W2979595568 hasConcept C164705383 @default.
- W2979595568 hasConcept C2775914520 @default.
- W2979595568 hasConcept C2776131983 @default.
- W2979595568 hasConcept C2778198053 @default.
- W2979595568 hasConcept C2778902805 @default.
- W2979595568 hasConcept C2779161974 @default.
- W2979595568 hasConcept C2780689522 @default.
- W2979595568 hasConcept C2781267111 @default.
- W2979595568 hasConcept C71924100 @default.
- W2979595568 hasConcept C78085059 @default.
- W2979595568 hasConceptScore W2979595568C126322002 @default.
- W2979595568 hasConceptScore W2979595568C141071460 @default.
- W2979595568 hasConceptScore W2979595568C164705383 @default.
- W2979595568 hasConceptScore W2979595568C2775914520 @default.
- W2979595568 hasConceptScore W2979595568C2776131983 @default.
- W2979595568 hasConceptScore W2979595568C2778198053 @default.
- W2979595568 hasConceptScore W2979595568C2778902805 @default.
- W2979595568 hasConceptScore W2979595568C2779161974 @default.
- W2979595568 hasConceptScore W2979595568C2780689522 @default.
- W2979595568 hasConceptScore W2979595568C2781267111 @default.
- W2979595568 hasConceptScore W2979595568C71924100 @default.
- W2979595568 hasConceptScore W2979595568C78085059 @default.
- W2979595568 hasIssue "10" @default.
- W2979595568 hasLocation W29795955681 @default.
- W2979595568 hasOpenAccess W2979595568 @default.
- W2979595568 hasPrimaryLocation W29795955681 @default.
- W2979595568 hasRelatedWork W1971470946 @default.
- W2979595568 hasRelatedWork W1985002112 @default.
- W2979595568 hasRelatedWork W2170721457 @default.
- W2979595568 hasRelatedWork W2356768786 @default.
- W2979595568 hasRelatedWork W2395122888 @default.
- W2979595568 hasRelatedWork W2607472074 @default.
- W2979595568 hasRelatedWork W2924472371 @default.
- W2979595568 hasRelatedWork W2994196607 @default.
- W2979595568 hasRelatedWork W3031716851 @default.
- W2979595568 hasRelatedWork W4200520898 @default.
- W2979595568 hasVolume "35" @default.
- W2979595568 isParatext "false" @default.
- W2979595568 isRetracted "false" @default.
- W2979595568 magId "2979595568" @default.
- W2979595568 workType "article" @default.